铜配合物在抗肿瘤治疗中的研究进展
Research progress of Copper complexes for antitumor therapy
杨煜雲 1黄艳利 2李军政3
作者信息
- 1. 贵州医科大学临床医学院,贵州贵阳 550004;暨南大学附属广州红十字会医院耳鼻咽喉头颈外科,广东 广州 510220
- 2. 贵州医科大学临床医学院,贵州贵阳 550004;湖北省仙桃市第一人民医院耳鼻咽喉科,湖北仙桃 433000
- 3. 贵州医科大学临床医学院,贵州贵阳 550004;南方医科大学珠江医院耳鼻咽喉头颈外科中心,广东 广州 510280
- 折叠
摘要
铜是人体必需元素之一,广泛参与着人体内各项生命活动,其稳态在原核细胞和真核细胞中受到严格调节,以确保有足够的铜用于蛋白质的生物合成,并抑制氧化应激的产生和毒性.铜已被公认为限制癌症发生发展的因素之一,因此,通过调节人体内铜含量从而影响肿瘤的发生发展已逐步成为肿瘤治疗的热点之一,其可分为通过含铜化合物或铜离子载体来增加肿瘤细胞中的铜浓度和通过铜络合剂将铜浓度降低至生理水平,从而达到抗肿瘤治疗.论文针对铜配合物在肿瘤治疗中的现状与进展作一简要概述,包括已知的作用机制、分子靶点,讨论相关的临床试验,对其前景进行展望.
Abstract
Copper is one of the essential elements required by the human body,being widely involved in various activities.Copper homeostasis is strictly regulated in prolcaryotic and eukaryotic cells to ensure sufficient copper availability for protein biosynthesis and the inhibition of oxidative stress and resulting toxicity.Copper is a limiting factor in the development and progression of cancer,including growth,angiogenesis and metastasis;Therefore,regulating tumor occurrence and development by varying the copper con-tent in the human body has become a popular research topic in tumor treatment.The method adopted for this can be divided into those that increase the copper concentration in tumor cells by administering copper compounds or copper ionophores and those that reduce the copper concentration to physiological levele using copper complexing agents,thereby achieving antitumor therapy.In this paper,the current status and progress of copper complexes in tumor therapy are briefly reviewed,including the known mechanism of action and molecular targets,Furthermore,the related clinical trials are discussed,and the prospects for copper complexes in this field are outlined.
关键词
铜配合物/抗肿瘤治疗/铜死亡/铜离子载体Key words
Copper complex/Antineoplaston/Copper death/Copper ion carrier引用本文复制引用
基金项目
广州市科技计划项目(202102010041)
出版年
2024
NETL
NSTL
万方数据